In situ forming, resorbable graft copolymer hydrogels providing controlled drug release

Journal of Biomedical Materials Research - Part A

Volumn 101 A, Issue 5, 2013, Pages 1437-1446

  Overstreet, Derek J ^a   Huynh, Richard ^a   Jarbo, Keith ^b   McLemore, Ryan Y ^b   Vernon, Brent L ^a  

^a Arizona State University   (United States)

^b BANNER GOOD SAMARITAN MEDICAL CENTER   (United States)

Author keywords

antimicrobials; controlled release; graft copolymer; injectable; N isopropylacrylamide

Indexed keywords

ANTIMICROBIALS; CONTROLLED DRUG RELEASE; CONTROLLED RELEASE; DEGRADATION BY-PRODUCTS; DRUG DELIVERY VEHICLES; INJECTABLE; IRREGULAR GEOMETRIES; N-ISOPROPYLACRYLAMIDES;

ACRYLIC MONOMERS; BYPRODUCTS; CELL CULTURE; CONTROLLED DRUG DELIVERY; DRUG PRODUCTS; GELATION; GELS; GRAFT COPOLYMERS; PHASE SEPARATION; POLYMERS;

HYDROGELS;

ALPHA ACRYLOYLOXY BETA,BETA DIMETHYL GAMMA BUTYROLACTONE; CEFAZOLIN; COPOLYMER; JEFFAMINE M 1000 ACRYLAMIDE; POLY(N ISOPROPYLACRYLAMIDE); UNCLASSIFIED DRUG; VANCOMYCIN;

ANIMAL CELL; ARTICLE; BODY TEMPERATURE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DEGRADATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; FIBROBLAST; GELATION; HYDROGEL; MOUSE; NONHUMAN; PHASE SEPARATION; SUSTAINED DRUG RELEASE; WATER CONTENT;

4-BUTYROLACTONE; ACRYLAMIDES; ANIMALS; ANTI-BACTERIAL AGENTS; BIOCOMPATIBLE MATERIALS; CEFAZOLIN; DELAYED-ACTION PREPARATIONS; HYDROGELS; MICE; NIH 3T3 CELLS; VANCOMYCIN; WATER;

EID: 84875467003     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.34443     Document Type: Article

References (43)

1. Van Dyke TE, Offenbacher S, Braswell L, Lessem J,. Enhancing the value of scaling and root-planing: Arestin clinical trial results. J Int Acad Periodontol 2002; 4: 72-76.
2. Peeling WB,. Phase III studies to compare goserelin (Zoladex) with orchiectomy and with diethylstilbestrol in treatment of prostatic carcinoma. Urology 1989; 33 (5 Suppl): 45-52.
3. Cui Z, Lee BH, Vernon BL,. New hydrolysis-dependent thermosensitive polymer for an injectable degradable system. Biomacromolecules 2007; 8: 1280-1286.
4. Li Z, Wang F, Roy S, Sen CK, Guan J,. Injectable, highly flexible, and thermosensitive hydrogels capable of delivering superoxide dismutase. Biomacromolecules 2009 14; 10: 3306-3316.
5. Nelson DM, Ma Z, Leeson CE, Wagner WR,. Extended and sequential delivery of protein from injectable thermoresponsive hydrogels. J Biomed Mater Res A 2012; 100: 776-785.
6. Morscher EW, Hefti A, Aebi U,. Severe osteolysis after third-body wear due to hydroxyapatite particles from acetabular cup coating. J Bone Joint Surg Br 1998; 80: 267-272.
7. Trumpy IG, Lyberg T,. In vivo deterioration of proplast-teflon temporomandibular joint interpositional implants: A scanning electron microscopic and energy-dispersive X-ray analysis. J Oral Maxillofac Surg 1993; 51: 624-629.
8. Alt V, Bitschnau A, Böhner F, Heerich KE, Magesin E, Sewing A, et al. Effects of gentamicin and gentamicin-RGD coatings on bone ingrowth and biocompatibility of cementless joint prostheses: An experimental study in rabbits. Acta Biomaterialia 2011; 7: 1274-1280.
9. Landes CA, Ballon A, Roth C,. In-patient versusin vitro degradation of P(L/DL)LA and PLGA. J Biomed Mater Res B 2006; 76: 403-411.
10. Heskins M, Guillet JE,. Solution properties of poly(N- isopropylacrylamide). J Macromol Sci Chem 1968; 2: 1441-1455.
11. Schild HG, Tirrell DA,. Microcalorimetric detection of lower critical solution temperatures in aqueous polymer solutions. J Phys Chem 1990; 94: 4352-4356.
12. Schild HG,. Poly(N-isopropylacrylamide): Experiment, theory and application. Prog Polym Sci 1992; 17: 163-249.
13. Lee BH, Vernon B,. Copolymers of N-isopropylacrylamide, HEMA-lactate and acrylic acid with time-dependent lower critical solution temperature as a bioresorbable carrier. Polym Int 2005; 54: 418-422.
14. Ma Z, Nelson DM, Hong Y, Wagner WR,. Thermally responsive injectable hydrogel incorporating methacrylate-polylactide for hydrolytic lability. Biomacromolecules 2010; 11: 1873-1881.
15. Overstreet DJ, Dhruv HD, Vernon BL,. Bioresponsive copolymers of poly (N-isopropylacrylamide) with enzyme-dependent lower critical solution temperatures. Biomacromolecules 2010; 11: 1154-1159.
16. Leon C, Solis FJ, Vernon B,. Phase behavior and shrinking kinetics of thermo-reversible poly(N-isopropylacrylamide-2-hydroxyethyl methacrylate). Mater Res Soc Symp Proc 2009; 1190.
17. Kaneko Y, Nakamura S, Sakai K, Aoyagi T, Kikuchi A, Sakurai Y, et al. Rapid deswelling response of poly (N-isopropylacrylamide) hydrogels by the formation of water release channels using poly(ethylene oxide) graft chains. Macromolecules 1998; 31: 6099-6105.
18. Stile RA, Burghardt WR, Healy KE,. Synthesis and characterization of injectable poly(N-isopropylacrylamide)-based hydrogels that support tissue formation in vitro. Macromolecules 1999; 32: 7370-7379.
19. Vernon BL, Kim SW, Bae YH,. Thermoreversible copolymer gels for extracellular matrix. J Biomed Mater Res A 2000; 51: 69-79.
20. Lee BH, West B, McLemore R, Pauken C, Vernon BL,. In-situ injectable physically and chemically gelling NIPAAm-based copolymer system for embolization. Biomacromolecules 2006; 7: 2059-2064.
21. Gutowska A, Bark JS, Kwon IC, Bae YH, Cha Y, Kim SW,. Squeezing hydrogels for controlled oral drug delivery. J Control Rel 1997; 48 (2-3): 141-148.
22. Gutowska A, Bae YH, Feijen J, Kim SW,. Heparin release from thermosensitive hydrogels. J Control Rel 1992; 22: 95-104.
23. Milasinovic N, Kalagasidis Krusic M, Knezevic-Jugovic Z, Filipovic J,. Hydrogels of N-isopropylacrylamide copolymers with controlled release of a model protein. Int J Pharm 2010; 383 (1-2): 53-61.
24. Overstreet DJ, McLemore RY, Doan BD, Farag A, Vernon BL,. Temperature-responsive graft copolymer hydrogels for controlled swelling and drug delivery. Soft Materials. In Press.
25. Okano T, Bae YH, Jacobs H, Kim SW,. Thermally on-off switching polymers for drug permeation and release. J Control Rel 1990; 11 (1-3): 255-265.
26. Bae YH, Okano T, Kim SW,. "On-Off" thermocontrol of solute transport. II. Solute release from thermosensitive hydrogels. Pharm Res 1991; 8: 624-628.
27. Garbern JC, Hoffman AS, Stayton PS,. Injectable pH- and temperature-responsive poly(N-isopropylacrylamide-co-propylacrylic acid) copolymers for delivery of angiogenic growth factors. Biomacromolecules 2010; 11: 5891-5905.
28. Kizhakkedathu JN, Janzen J, Le Y, Kainthan RK, Brooks DE,. Poly(oligo(ethylene glycol)acrylamide) brushes by surface initiated polymerization: Effect of macromonomer chain length on brush growth and protein adsorption from blood plasma. Langmuir 2009; 25: 3794-3801.
29. Jeong B, Bae YH, Kim SW,. Drug release from biodegradable injectable thermosensitive hydrogel of PEG-PLGA-PEG triblock copolymers. J Control Rel 2000; 63: 155-163.
30. Potta T, Chun CJ, Song SC,. Design of polyphosphazene hydrogels with improved structural properties by use of star-shaped multithiol crosslinkers. Macromol Biosci 2011; 11: 689-699.
31. Galperin A, Long TJ, Ratner BD,. Degradable, thermo-sensitive poly(N-isopropylacrylamide)-based scaffolds with controlled porosity for tissue engineering applications. Biomacromolecules 2010; 11: 2583-2592.
32. DeNardo SJ, Yao Z, Lam KS, Song A, Burke PA, Mirick GR, et al. Effect of molecular size of pegylated peptide on the pharmacokinetics and tumor targeting in lymphoma-bearing mice. Clin Cancer Res 2003; 9: 3854S-3864S.
33. Henderson E, Lee BH, Cui Z, McLemore R, Brandon TA, Vernon BL,. In vivo evaluation of injectable thermosensitive polymer with time-dependent LCST. J Biomed Mater Res A 2009; 90: 1186-1197.
34. Peppas NA, Khare AR,. Preparation, structure and diffusional behavior of hydrogels in controlled release. Adv Drug Deliv Rev 1993; 11 (1-2): 1-35.
35. Lin HH, Cheng YL,. In-situ thermoreversible gelation of block and star copolymers of poly(ethylene glycol) and poly(N-isopropylacrylamide) of varying architectures. Macromolecules 2001; 34: 3710-3715.
36. Mathew M, Das Gupta V,. Stability of vancomycin hydrochloride solutions at various pH values as determined by high-performance liquid chromatography. Drug Dev Ind Pharm 1995; 21: 257-264.
37. Antipas AS, Velde DV, Stella VJ,. Factors affecting the deamidation of vancomycin in aqueous solutions. Int J Pharm 1994; 109: 261-269.
38. Ahmed I, Day P,. Stability of cefazolin sodium in various artificial tear solutions and aqueous vehicles. Am J Hosp Pharm 1987; 44: 2287-2290.
39. Galanti LM, Hecq JD, Vanbeckbergen D, Jamart J,. Long-term stability of cefuroxime and cefazolin sodium in intravenous infusions. J Clin Pharm Ther 1996; 21: 185-189.
40. Vernon BL, Fusaro F, Borden B, Roy KH,. Partition-controlled progesterone release from waterborne, in situ-gelling materials. Int J Pharm 2004; 274 (1-2): 191-200.
41. Miller R, McLaren A, Leon C, McLemore R,. Mixing method affects elution and strength of high-dose ALBC: A pilot study. Clin Orthop Relat Res 2012; 470: 2677-2683.
42. Hsieh P-H, Shih C-H, Chang Y-H, Lee MS, Shih H-N, Yang W-E,. Two-stage revision hip arthroplasty for infection: Comparison between the interim use of antibiotic-loaded cement beads and a spacer prosthesis. J Bone Joint Surg Am 2004; 86: 1989-1997.
43. Moran JM, Greenwald AS, Matejczyk M-B,. Effect of gentamicin on shear and interface strengths of bone cement. Clin Orthop Relat Res 1979; 141: 96-101.